News about Alois Alzheimer

Why eating one chip is like smoking a cigarette: DR CATHERINE SHANAHAN reveals the vegetable oils hidden in everyday foods that could make you ill

www.dailymail.co.uk, June 4, 2024
Next time you go to the supermarket, read the ingredients lists. In just about every aisle, from dairy to frozen foods and snacks, you will see vegetable oils making repeated appearances on many product labels, including salad dressings, canned fish, ready-to-eat foods, diet drinks and infant formulas. These oils, usually made from seeds, include sunflower, corn, rapeseed, soy, cottonseed and safflower oils. Vegetable oil is a global industry. It generated more than £91 billion in 2020, and that figure is forecast to increase to £127 billion by 2027.

Are we FINALLY close to solving the Alzheimer's puzzle? Scientists now have drugs and screening kits after decades of failures in the fight against cruel disease, although warnings rates could increase in the coming years

www.dailymail.co.uk, January 23, 2024
Scientists backed by billions of pounds are now, one step closer to thwarting Alzheimer's disease, according to decades of painful study. Although a cure has so far escaped pharmaceutical companies, game-changing drugs that stop the memory-robbing disease in its tracks have appeared (left graph). However, one problem remains: diagnosing Alzheimer's can be very difficult. Patients must perform a slew of tests, including scans and lumbar puncture, with some requiring waits of up to four years for their diagnosis, while others die before being told they have the disorder. That's why top neurologists are so excited by the new medical breakthrough, which is a simple blood test that can often detect Alzheimer's disease in the brain up to 15 years before symptoms appear.

Why lecanemab is the 'real deal' in the fight against Alzheimer's

www.dailymail.co.uk, November 30, 2022
Since the drug was discovered to slow cognitive decline in Alzheimer's in the 1980s, Europe, and Asia, scientists have spent more than a century struggling with the disease that robs people of their identity and self-determination. Lecanemab's groundbreaking trial findings, which show that it can both slow cognitive decline and investigate what is believed to be the root cause, were published today as the 'beginning of the end' for Alzheimer's. World-renowned experts, who are on the lookout for a way to reverse the memory-robbing disorder's course after years of punishing setbacks, have also named it the 'true deal,', and Professor John Hardy is hopeful of finding a cure.